Severe COVID-19 in an APS1 patient with interferon autoantibodies treated with plasmapheresis-Reference-Cited by-同舟云学术

Severe COVID-19 in an APS1 patient with interferon autoantibodies treated with plasmapheresis

Published:2021-07 Issue:1 Volume:148 Page:96-98
ISSN:0091-6749
Container-title:Journal of Allergy and Clinical Immunology
language:en
Short-container-title:Journal of Allergy and Clinical Immunology

Author:

Lemarquis Andri^ORCID,Campbell Tessa,Aranda-Guillén Maribel,Hennings Viktoria,Brodin Petter,Kämpe Olle,Blennow Kaj,Zetterberg Henrik,Wennerås Christine,Eriksson Kristina,Landegren Nils,Bryceson Yenan,Berg Stefan,Ekwall Olov

Funder

Swedish Research Council

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference5 articles.

1. Autoantibodies against type I IFNs in patients with life-threatening COVID-19;Bastard;Science,2020

2. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19;Zhang;Science,2020

3. Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients;Hadjadj;Science,2020

4. Therapeutic plasma exchange: review of current indications;Fernández-Zarzoso;Transfus Apher Sci,2019

5. Anti-interferon autoantibodies in autoimmune polyendocrinopathy syndrome type 1;Meager;PLoS Med,2006

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In search of a function for human type III interferons: insights from inherited and acquired deficits;Current Opinion in Immunology;2024-04

2. No link between type I interferon autoantibody positivity and adverse reactions to COVID-19 vaccines;npj Vaccines;2024-02-22

3. Restrained memory CD8⁺T cell responses favors viral persistence and elevated IgG responses in patients with severe Long COVID;2024-02-13

4. Severe pediatric COVID-19: a review from the clinical and immunopathophysiological perspectives;World Journal of Pediatrics;2024-02-06

5. Evaluation of Genetic or Cellular Impairments in Type I IFN Immunity in a Cohort of Young Adults with Critical COVID-19;Journal of Clinical Immunology;2024-01-17